Evidence map›Paper›PMID 40389663›Full record

ArticleNature cardiovascular research2025

Mineralocorticoid receptor phase separation modulates cardiac preservation.

Ienglam Lei, Hüseyin Sicim, Wenbin Gao, Wei Huang, Pierre Emmanuel Noly, Melissa R Pergande, Mallory C Wilson, Aurora Lee, Liu Liu, Ashraf Abou El Ela and 12 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ienglam LeiDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0248-6871
Hüseyin SicimDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-3430-3862
Wenbin GaoDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9268-8823
Wei HuangDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Pierre Emmanuel NolyDepartment of Cardiac Surgery, Université de Montréal, Montréal, Quebec, Canada.
Melissa R PergandeDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI, USA.
Mallory C WilsonDepartment of Chemistry, University of Wisconsin, Madison, WI, USA.
Aurora LeeDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0009-0000-4607-5188
Liu LiuDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Ashraf Abou El ElaDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Mulan JiangDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Sahar A SaddoughiDepartment of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.
Jordan S PoberDepartment of Pathology, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5990-1071
Jeffrey L PlattDepartment of Surgery, University of Michigan, Ann Arbor, MI, USA.
Marilia CascalhoDepartment of Surgery, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0002-2695-3921
Francis D PaganiDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-4430-9969
Y Eugene ChenDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0003-2357-7825
Bertram PittDepartment of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI, USA.
Zhong WangDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, MI, USA.
Richard M MortensenDepartment of Molecular and Integrative Physiology, Internal Medicine, Pharmacology, University of Michigan, Ann Arbor, MI, USA.
Ying GeDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI, USA.
Paul C TangDepartment of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA. tang.paul2@mayo.edu.ORCID http://orcid.org/0000-0003-4211-8587

Funding

Training Program in Translational Cardiovascular Science (TPTCS)T32HL007936 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Lee Lochbaum Eckhardt, Gail A Robertson · 2001 to 2026
$11.6M
Using genetics to discover mechanisms of myocardial infarctionR01HL109946 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI YUQING Eugene CHEN, Ida Liisa Surakka · 2011 to 2026
$8.9M
KLF14 and Cardiovascular DiseaseR01HL134569 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2017 to 2024
$5.3M
Deciphering Myofilament Modifications in Ischemic CardiomyopathyR01HL109810 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GE, YING · 2013 to 2024
$3.5M
Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for TransplantationR01HL164416 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Paul Tang · 2022 to 2026
$3.3M
TNFRSF13B polymorphisms and immunity to transplantationR01AI173950 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARILIA Isabel CASCALHO, Jeffrey L Platt · 2023 to 2026
$3.1M
Donor-specific B cells in Transplantation.R01AI151588 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASCALHO, MARILIA ISABEL, PLATT, JEFFREY L · 2020 to 2025
$2.7M
Targeting Mineralocorticoid Receptor Condensates to Optimize Donor Heart PreservationR01HL166140 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Paul Tang · 2023 to 2026
$2.7M
Browning of perivascular adipose tissue protects against thoracic aortic aneurysmR01HL159871 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2022 to 2025
$2.3M
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft EndotheliumU01AI132895 · NIAID · YALE UNIVERSITY · PI POBER, JORDAN S, SALTZMAN, W. MARK · 2017 to 2021
$2.2M
Graduate Training in Cellular and Molecular Pathogenesis of Human DiseasesT32GM135119 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Zsuzsanna Fabry · 2020 to 2026
$2.2M
Dissecting a post-translational modification code in cardiac reprogrammingR01HL163672 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, ZHONG · 2022 to 2025
$1.8M
American Heart Association (American Heart Association, Inc.) 930124NHLBI NIH HHS R01 HL109810NHLBI NIH HHS R01 HL109946NHLBI NIH HHS R01 HL134569NHLBI NIH HHS R01 HL139735NHLBI NIH HHS R01 HL159871NHLBI NIH HHS R01 HL163672NHLBI NIH HHS R01 HL164416NHLBI NIH HHS R01 HL166140NHLBI NIH HHS T32 HL007936NIAID NIH HHS R01 AI151588NIAID NIH HHS R01 AI173950NIAID NIH HHS U01 AI132895NIGMS NIH HHS T32 GM135119U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL109810U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL109946U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL134569U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL139735U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL159871U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL163672U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL164416U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL166140U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI151588U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI173950U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U01-AI132895U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM135119
6 · The paper itself

Abstract

Heart transplantation is the gold standard treatment for patients with end-stage heart failure. However, there is a shortage of donor hearts available. The short tolerable cold ischemic time for delivering donor hearts to matching recipients is closely responsible for this shortage. Here we uncover the phenomenon of mineralocorticoid receptor (MR) phase separation, which exacerbates injury to the murine and human donor heart during cold storage and can be modulated with pharmacological inhibition to improve preservation quality. Interestingly, donor cardiomyocytes strongly expressed MR, which undergoes preservation-related phase separation. The phenomenon of macromolecular phase separation is not limited to the heart or MR during preservation. Cold preservation of the lung, liver and kidney also displays phase separation of other transcriptional regulators including histone deacetylase 1 (HDAC1), bromodomain-containing 4 (BRD4) and MR. Our results reveal an understudied area of preservation biology that may be further exploited to improve the preservation of multiple solid organs.

Indexed as

Heart TransplantationMyocytes, CardiacOrgan PreservationReceptors, MineralocorticoidAnimalsCell Cycle ProteinsCold IschemiaHistone Deacetylase 1HumansKidneyLiverLungMaleMiceMice, Inbred C57BLMineralocorticoid Receptor AntagonistsCell Cycle ProteinsHistone Deacetylase 1Mineralocorticoid Receptor AntagonistsNuclear ProteinsReceptors, MineralocorticoidTranscription Factors

Identifiers

PMID40389663
PMCPMC12239668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.